Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > In Vivo Gene Delivery Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

In Vivo Gene Delivery Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

In Vivo Gene Delivery Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-10-29

Pages: 105 Pages

Report ld: 5291076

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for In Vivo Gene Delivery Instrument was estimated to be worth US$ 73.50 million in 2024 and is forecast to a readjusted size of US$ 124 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on In Vivo Gene Delivery Instrument cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In Vivo Gene Delivery Instrument Market Size(US$)

M= millions and B=billions

QYRLogo
In 2024, global production of In Vivo Gene Delivery Instrument reached approximately 3,500 units, with an average selling price of approximately US$21,000 per unit. The single-line production capacity is approximately 180 units per year, with an average gross profit margin of approximately 40-50%. In Vivo Gene Delivery Instrument use specific electric fields or physical methods to introduce exogenous genes or other substances into living cells or tissues. They transiently increase the permeability of cell membranes, allowing DNA and other substances to enter cells, thereby achieving gene transfer and expression. They are widely used in cell engineering, gene therapy, and DNA vaccine research. 
Upstream raw materials primarily include precision mechanical parts (frames, syringe pumps), electronic components (high-voltage pulse generators, circuit boards, chips), specialty materials (medical-grade plastics, precious metal electrodes), and supporting biochemical reagents. Downstream applications directly serve cutting-edge biotechnology fields, focusing on cell engineering, gene therapy, gene editing, and DNA vaccines.

North American market for In Vivo Gene Delivery Instrument was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for In Vivo Gene Delivery Instrument was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for In Vivo Gene Delivery Instrument was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of In Vivo Gene Delivery Instrument include BTX, Gibco, Lonza, Bio-Rad, BEX, Ningbo Scientz Biotechnology, Shanghai Qiwen Biotechnology, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for In Vivo Gene Delivery Instrument, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of In Vivo Gene Delivery Instrument by region & country, by Type, and by Application.

The In Vivo Gene Delivery Instrument market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Gene Delivery Instrument.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • In Vivo Gene Delivery Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  • Forecasted Market Size in 2031

  • US$ 124 million

  • CAGR(2025-2031)

  • 7.8%

  • Market Size Available for Years

  • 2025-2031

  • Global In Vivo Gene Delivery Instrument Companies Covered

  • BTX

    Gibco

    Lonza

    Bio-Rad

    BEX

    Ningbo Scientz Biotechnology

    Shanghai Qiwen Biotechnology

  • Global In Vivo Gene Delivery Instrument Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global In Vivo Gene Delivery Instrument Market, Segment by Type

  • Electroporation

    Gene Gun

    Hydrodynamic Injection

    Microinjection

    Other

  • Global In Vivo Gene Delivery Instrument Market, Segment by Application

  • Cell Engineering

    Gene Therapy

    Gene Editing

    DNA Vaccine

    Other

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of In Vivo Gene Delivery Instrument manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of In Vivo Gene Delivery Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of In Vivo Gene Delivery Instrument in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 In Vivo Gene Delivery Instrument Product Introduction
    1.2 Global In Vivo Gene Delivery Instrument Market Size Forecast
        1.2.1 Global In Vivo Gene Delivery Instrument Sales Value (2020-2031)
        1.2.2 Global In Vivo Gene Delivery Instrument Sales Volume (2020-2031)
        1.2.3 Global In Vivo Gene Delivery Instrument Sales Price (2020-2031)
    1.3 In Vivo Gene Delivery Instrument Market Trends & Drivers
        1.3.1 In Vivo Gene Delivery Instrument Industry Trends
        1.3.2 In Vivo Gene Delivery Instrument Market Drivers & Opportunity
        1.3.3 In Vivo Gene Delivery Instrument Market Challenges
        1.3.4 In Vivo Gene Delivery Instrument Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global In Vivo Gene Delivery Instrument Players Revenue Ranking (2024)
    2.2 Global In Vivo Gene Delivery Instrument Revenue by Company (2020-2025)
    2.3 Global In Vivo Gene Delivery Instrument Players Sales Volume Ranking (2024)
    2.4 Global In Vivo Gene Delivery Instrument Sales Volume by Company Players (2020-2025)
    2.5 Global In Vivo Gene Delivery Instrument Average Price by Company (2020-2025)
    2.6 Key Manufacturers In Vivo Gene Delivery Instrument Manufacturing Base and Headquarters
    2.7 Key Manufacturers In Vivo Gene Delivery Instrument Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of In Vivo Gene Delivery Instrument
    2.9 In Vivo Gene Delivery Instrument Market Competitive Analysis
        2.9.1 In Vivo Gene Delivery Instrument Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by In Vivo Gene Delivery Instrument Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Gene Delivery Instrument as of 2024)
    2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Electroporation
        3.1.2 Gene Gun
        3.1.3 Hydrodynamic Injection
        3.1.4 Microinjection
        3.1.5 Other
    3.2 Global In Vivo Gene Delivery Instrument Sales Value by Type
        3.2.1 Global In Vivo Gene Delivery Instrument Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global In Vivo Gene Delivery Instrument Sales Value, by Type (2020-2031)
        3.2.3 Global In Vivo Gene Delivery Instrument Sales Value, by Type (%) (2020-2031)
    3.3 Global In Vivo Gene Delivery Instrument Sales Volume by Type
        3.3.1 Global In Vivo Gene Delivery Instrument Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global In Vivo Gene Delivery Instrument Sales Volume, by Type (2020-2031)
        3.3.3 Global In Vivo Gene Delivery Instrument Sales Volume, by Type (%) (2020-2031)
    3.4 Global In Vivo Gene Delivery Instrument Average Price by Type (2020-2031)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Cell Engineering
        4.1.2 Gene Therapy
        4.1.3 Gene Editing
        4.1.4 DNA Vaccine
        4.1.5 Other
    4.2 Global In Vivo Gene Delivery Instrument Sales Value by Application
        4.2.1 Global In Vivo Gene Delivery Instrument Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global In Vivo Gene Delivery Instrument Sales Value, by Application (2020-2031)
        4.2.3 Global In Vivo Gene Delivery Instrument Sales Value, by Application (%) (2020-2031)
    4.3 Global In Vivo Gene Delivery Instrument Sales Volume by Application
        4.3.1 Global In Vivo Gene Delivery Instrument Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global In Vivo Gene Delivery Instrument Sales Volume, by Application (2020-2031)
        4.3.3 Global In Vivo Gene Delivery Instrument Sales Volume, by Application (%) (2020-2031)
    4.4 Global In Vivo Gene Delivery Instrument Average Price by Application (2020-2031)
5 Segmentation by Region
    5.1 Global In Vivo Gene Delivery Instrument Sales Value by Region
        5.1.1 Global In Vivo Gene Delivery Instrument Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global In Vivo Gene Delivery Instrument Sales Value by Region (2020-2025)
        5.1.3 Global In Vivo Gene Delivery Instrument Sales Value by Region (2026-2031)
        5.1.4 Global In Vivo Gene Delivery Instrument Sales Value by Region (%), (2020-2031)
    5.2 Global In Vivo Gene Delivery Instrument Sales Volume by Region
        5.2.1 Global In Vivo Gene Delivery Instrument Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global In Vivo Gene Delivery Instrument Sales Volume by Region (2020-2025)
        5.2.3 Global In Vivo Gene Delivery Instrument Sales Volume by Region (2026-2031)
        5.2.4 Global In Vivo Gene Delivery Instrument Sales Volume by Region (%), (2020-2031)
    5.3 Global In Vivo Gene Delivery Instrument Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        5.4.2 North America In Vivo Gene Delivery Instrument Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        5.5.2 Europe In Vivo Gene Delivery Instrument Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        5.6.2 Asia Pacific In Vivo Gene Delivery Instrument Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        5.7.2 South America In Vivo Gene Delivery Instrument Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        5.8.2 Middle East & Africa In Vivo Gene Delivery Instrument Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions In Vivo Gene Delivery Instrument Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions In Vivo Gene Delivery Instrument Sales Value and Sales Volume
        6.2.1 Key Countries/Regions In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        6.2.2 Key Countries/Regions In Vivo Gene Delivery Instrument Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        6.3.2 United States In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States In Vivo Gene Delivery Instrument Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        6.4.2 Europe In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe In Vivo Gene Delivery Instrument Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        6.5.2 China In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
        6.5.3 China In Vivo Gene Delivery Instrument Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        6.6.2 Japan In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan In Vivo Gene Delivery Instrument Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        6.7.2 South Korea In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea In Vivo Gene Delivery Instrument Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        6.8.2 Southeast Asia In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia In Vivo Gene Delivery Instrument Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India In Vivo Gene Delivery Instrument Sales Value, 2020-2031
        6.9.2 India In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
        6.9.3 India In Vivo Gene Delivery Instrument Sales Value by Application, 2024 VS 2031
7 Company Profiles
    7.1 BTX
        7.1.1 BTX Company Information
        7.1.2 BTX Introduction and Business Overview
        7.1.3 BTX In Vivo Gene Delivery Instrument Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 BTX In Vivo Gene Delivery Instrument Product Offerings
        7.1.5 BTX Recent Development
    7.2 Gibco
        7.2.1 Gibco Company Information
        7.2.2 Gibco Introduction and Business Overview
        7.2.3 Gibco In Vivo Gene Delivery Instrument Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Gibco In Vivo Gene Delivery Instrument Product Offerings
        7.2.5 Gibco Recent Development
    7.3 Lonza
        7.3.1 Lonza Company Information
        7.3.2 Lonza Introduction and Business Overview
        7.3.3 Lonza In Vivo Gene Delivery Instrument Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Lonza In Vivo Gene Delivery Instrument Product Offerings
        7.3.5 Lonza Recent Development
    7.4 Bio-Rad
        7.4.1 Bio-Rad Company Information
        7.4.2 Bio-Rad Introduction and Business Overview
        7.4.3 Bio-Rad In Vivo Gene Delivery Instrument Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Bio-Rad In Vivo Gene Delivery Instrument Product Offerings
        7.4.5 Bio-Rad Recent Development
    7.5 BEX
        7.5.1 BEX Company Information
        7.5.2 BEX Introduction and Business Overview
        7.5.3 BEX In Vivo Gene Delivery Instrument Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 BEX In Vivo Gene Delivery Instrument Product Offerings
        7.5.5 BEX Recent Development
    7.6 Ningbo Scientz Biotechnology
        7.6.1 Ningbo Scientz Biotechnology Company Information
        7.6.2 Ningbo Scientz Biotechnology Introduction and Business Overview
        7.6.3 Ningbo Scientz Biotechnology In Vivo Gene Delivery Instrument Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Ningbo Scientz Biotechnology In Vivo Gene Delivery Instrument Product Offerings
        7.6.5 Ningbo Scientz Biotechnology Recent Development
    7.7 Shanghai Qiwen Biotechnology
        7.7.1 Shanghai Qiwen Biotechnology Company Information
        7.7.2 Shanghai Qiwen Biotechnology Introduction and Business Overview
        7.7.3 Shanghai Qiwen Biotechnology In Vivo Gene Delivery Instrument Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Shanghai Qiwen Biotechnology In Vivo Gene Delivery Instrument Product Offerings
        7.7.5 Shanghai Qiwen Biotechnology Recent Development
8 Industry Chain Analysis
    8.1 In Vivo Gene Delivery Instrument Industrial Chain
    8.2 In Vivo Gene Delivery Instrument Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 In Vivo Gene Delivery Instrument Sales Model
        8.5.2 Sales Channel
        8.5.3 In Vivo Gene Delivery Instrument Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. In Vivo Gene Delivery Instrument Market Trends
 Table 2. In Vivo Gene Delivery Instrument Market Drivers & Opportunity
 Table 3. In Vivo Gene Delivery Instrument Market Challenges
 Table 4. In Vivo Gene Delivery Instrument Market Restraints
 Table 5. Global In Vivo Gene Delivery Instrument Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global In Vivo Gene Delivery Instrument Revenue Market Share by Company (2020-2025)
 Table 7. Global In Vivo Gene Delivery Instrument Sales Volume by Company (2020-2025) & (Units)
 Table 8. Global In Vivo Gene Delivery Instrument Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market In Vivo Gene Delivery Instrument Price by Company (2020-2025) & (K US$/Unit)
 Table 10. Key Manufacturers In Vivo Gene Delivery Instrument Manufacturing Base and Headquarters
 Table 11. Key Manufacturers In Vivo Gene Delivery Instrument Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of In Vivo Gene Delivery Instrument
 Table 13. Global In Vivo Gene Delivery Instrument Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Gene Delivery Instrument as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global In Vivo Gene Delivery Instrument Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global In Vivo Gene Delivery Instrument Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global In Vivo Gene Delivery Instrument Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global In Vivo Gene Delivery Instrument Sales Market Share in Value by Type (2020-2025)
 Table 20. Global In Vivo Gene Delivery Instrument Sales Market Share in Value by Type (2026-2031)
 Table 21. Global In Vivo Gene Delivery Instrument Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
 Table 22. Global In Vivo Gene Delivery Instrument Sales Volume by Type (2020-2025) & (Units)
 Table 23. Global In Vivo Gene Delivery Instrument Sales Volume by Type (2026-2031) & (Units)
 Table 24. Global In Vivo Gene Delivery Instrument Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global In Vivo Gene Delivery Instrument Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global In Vivo Gene Delivery Instrument Price by Type (2020-2025) & (K US$/Unit)
 Table 27. Global In Vivo Gene Delivery Instrument Price by Type (2026-2031) & (K US$/Unit)
 Table 28. Global In Vivo Gene Delivery Instrument Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global In Vivo Gene Delivery Instrument Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global In Vivo Gene Delivery Instrument Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global In Vivo Gene Delivery Instrument Sales Market Share in Value by Application (2020-2025)
 Table 32. Global In Vivo Gene Delivery Instrument Sales Market Share in Value by Application (2026-2031)
 Table 33. Global In Vivo Gene Delivery Instrument Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
 Table 34. Global In Vivo Gene Delivery Instrument Sales Volume by Application (2020-2025) & (Units)
 Table 35. Global In Vivo Gene Delivery Instrument Sales Volume by Application (2026-2031) & (Units)
 Table 36. Global In Vivo Gene Delivery Instrument Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global In Vivo Gene Delivery Instrument Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global In Vivo Gene Delivery Instrument Price by Application (2020-2025) & (K US$/Unit)
 Table 39. Global In Vivo Gene Delivery Instrument Price by Application (2026-2031) & (K US$/Unit)
 Table 40. Global In Vivo Gene Delivery Instrument Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global In Vivo Gene Delivery Instrument Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global In Vivo Gene Delivery Instrument Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global In Vivo Gene Delivery Instrument Sales Value by Region (2020-2025) & (%)
 Table 44. Global In Vivo Gene Delivery Instrument Sales Value by Region (2026-2031) & (%)
 Table 45. Global In Vivo Gene Delivery Instrument Sales Volume by Region (Units): 2020 VS 2024 VS 2031
 Table 46. Global In Vivo Gene Delivery Instrument Sales Volume by Region (2020-2025) & (Units)
 Table 47. Global In Vivo Gene Delivery Instrument Sales Volume by Region (2026-2031) & (Units)
 Table 48. Global In Vivo Gene Delivery Instrument Sales Volume by Region (2020-2025) & (%)
 Table 49. Global In Vivo Gene Delivery Instrument Sales Volume by Region (2026-2031) & (%)
 Table 50. Global In Vivo Gene Delivery Instrument Average Price by Region (2020-2025) & (K US$/Unit)
 Table 51. Global In Vivo Gene Delivery Instrument Average Price by Region (2026-2031) & (K US$/Unit)
 Table 52. Key Countries/Regions In Vivo Gene Delivery Instrument Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions In Vivo Gene Delivery Instrument Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions In Vivo Gene Delivery Instrument Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions In Vivo Gene Delivery Instrument Sales Volume, (2020-2025) & (Units)
 Table 56. Key Countries/Regions In Vivo Gene Delivery Instrument Sales Volume, (2026-2031) & (Units)
 Table 57. BTX Company Information
 Table 58. BTX Introduction and Business Overview
 Table 59. BTX In Vivo Gene Delivery Instrument Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 60. BTX In Vivo Gene Delivery Instrument Product Offerings
 Table 61. BTX Recent Development
 Table 62. Gibco Company Information
 Table 63. Gibco Introduction and Business Overview
 Table 64. Gibco In Vivo Gene Delivery Instrument Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 65. Gibco In Vivo Gene Delivery Instrument Product Offerings
 Table 66. Gibco Recent Development
 Table 67. Lonza Company Information
 Table 68. Lonza Introduction and Business Overview
 Table 69. Lonza In Vivo Gene Delivery Instrument Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 70. Lonza In Vivo Gene Delivery Instrument Product Offerings
 Table 71. Lonza Recent Development
 Table 72. Bio-Rad Company Information
 Table 73. Bio-Rad Introduction and Business Overview
 Table 74. Bio-Rad In Vivo Gene Delivery Instrument Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 75. Bio-Rad In Vivo Gene Delivery Instrument Product Offerings
 Table 76. Bio-Rad Recent Development
 Table 77. BEX Company Information
 Table 78. BEX Introduction and Business Overview
 Table 79. BEX In Vivo Gene Delivery Instrument Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 80. BEX In Vivo Gene Delivery Instrument Product Offerings
 Table 81. BEX Recent Development
 Table 82. Ningbo Scientz Biotechnology Company Information
 Table 83. Ningbo Scientz Biotechnology Introduction and Business Overview
 Table 84. Ningbo Scientz Biotechnology In Vivo Gene Delivery Instrument Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 85. Ningbo Scientz Biotechnology In Vivo Gene Delivery Instrument Product Offerings
 Table 86. Ningbo Scientz Biotechnology Recent Development
 Table 87. Shanghai Qiwen Biotechnology Company Information
 Table 88. Shanghai Qiwen Biotechnology Introduction and Business Overview
 Table 89. Shanghai Qiwen Biotechnology In Vivo Gene Delivery Instrument Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. Shanghai Qiwen Biotechnology In Vivo Gene Delivery Instrument Product Offerings
 Table 91. Shanghai Qiwen Biotechnology Recent Development
 Table 92. Key Raw Materials Lists
 Table 93. Raw Materials Key Suppliers Lists
 Table 94. In Vivo Gene Delivery Instrument Downstream Customers
 Table 95. In Vivo Gene Delivery Instrument Distributors List
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources


List of Figures
 Figure 1. In Vivo Gene Delivery Instrument Product Picture
 Figure 2. Global In Vivo Gene Delivery Instrument Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global In Vivo Gene Delivery Instrument Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global In Vivo Gene Delivery Instrument Sales Volume (2020-2031) & (Units)
 Figure 5. Global In Vivo Gene Delivery Instrument Sales Price (2020-2031) & (K US$/Unit)
 Figure 6. In Vivo Gene Delivery Instrument Report Years Considered
 Figure 7. Global In Vivo Gene Delivery Instrument Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global In Vivo Gene Delivery Instrument Players Sales Volume Ranking (2024) & (Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by In Vivo Gene Delivery Instrument Revenue in 2024
 Figure 10. In Vivo Gene Delivery Instrument Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Electroporation Picture
 Figure 12. Gene Gun Picture
 Figure 13. Hydrodynamic Injection Picture
 Figure 14. Microinjection Picture
 Figure 15. Other Picture
 Figure 16. Global In Vivo Gene Delivery Instrument Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global In Vivo Gene Delivery Instrument Sales Value Market Share by Type, 2024 & 2031
 Figure 18. Global In Vivo Gene Delivery Instrument Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
 Figure 19. Global In Vivo Gene Delivery Instrument Sales Volume Market Share by Type, 2024 & 2031
 Figure 20. Global In Vivo Gene Delivery Instrument Price by Type (2020-2031) & (K US$/Unit)
 Figure 21. Product Picture of Cell Engineering
 Figure 22. Product Picture of Gene Therapy
 Figure 23. Product Picture of Gene Editing
 Figure 24. Product Picture of DNA Vaccine
 Figure 25. Product Picture of Other
 Figure 26. Global In Vivo Gene Delivery Instrument Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 27. Global In Vivo Gene Delivery Instrument Sales Value Market Share by Application, 2024 & 2031
 Figure 28. Global In Vivo Gene Delivery Instrument Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
 Figure 29. Global In Vivo Gene Delivery Instrument Sales Volume Market Share by Application, 2024 & 2031
 Figure 30. Global In Vivo Gene Delivery Instrument Price by Application (2020-2031) & (K US$/Unit)
 Figure 31. North America In Vivo Gene Delivery Instrument Sales Value (2020-2031) & (US$ Million)
 Figure 32. North America In Vivo Gene Delivery Instrument Sales Value by Country (%), 2024 VS 2031
 Figure 33. Europe In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Europe In Vivo Gene Delivery Instrument Sales Value by Country (%), 2024 VS 2031
 Figure 35. Asia Pacific In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific In Vivo Gene Delivery Instrument Sales Value by Region (%), 2024 VS 2031
 Figure 37. South America In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 38. South America In Vivo Gene Delivery Instrument Sales Value by Country (%), 2024 VS 2031
 Figure 39. Middle East & Africa In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 40. Middle East & Africa In Vivo Gene Delivery Instrument Sales Value by Country (%), 2024 VS 2031
 Figure 41. Key Countries/Regions In Vivo Gene Delivery Instrument Sales Value (%), (2020-2031)
 Figure 42. Key Countries/Regions In Vivo Gene Delivery Instrument Sales Volume (%), (2020-2031)
 Figure 43. United States In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 44. United States In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
 Figure 45. United States In Vivo Gene Delivery Instrument Sales Value by Application (%), 2024 VS 2031
 Figure 46. Europe In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 47. Europe In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
 Figure 48. Europe In Vivo Gene Delivery Instrument Sales Value by Application (%), 2024 VS 2031
 Figure 49. China In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 50. China In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
 Figure 51. China In Vivo Gene Delivery Instrument Sales Value by Application (%), 2024 VS 2031
 Figure 52. Japan In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 53. Japan In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
 Figure 54. Japan In Vivo Gene Delivery Instrument Sales Value by Application (%), 2024 VS 2031
 Figure 55. South Korea In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 56. South Korea In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
 Figure 57. South Korea In Vivo Gene Delivery Instrument Sales Value by Application (%), 2024 VS 2031
 Figure 58. Southeast Asia In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 59. Southeast Asia In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
 Figure 60. Southeast Asia In Vivo Gene Delivery Instrument Sales Value by Application (%), 2024 VS 2031
 Figure 61. India In Vivo Gene Delivery Instrument Sales Value, (2020-2031) & (US$ Million)
 Figure 62. India In Vivo Gene Delivery Instrument Sales Value by Type (%), 2024 VS 2031
 Figure 63. India In Vivo Gene Delivery Instrument Sales Value by Application (%), 2024 VS 2031
 Figure 64. In Vivo Gene Delivery Instrument Industrial Chain
 Figure 65. In Vivo Gene Delivery Instrument Manufacturing Cost Structure
 Figure 66. Channels of Distribution (Direct Sales, and Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed

Description

The global market for In Vivo Gene Delivery Instrument was estimated to be worth US$ 73.50 million in 2024 and is forecast to a readjusted size of US$ 124 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on In Vivo Gene Delivery Instrument cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global production of In Vivo Gene Delivery Instrument reached approximately 3,500 units, with an average selling price of approximately US$21,000 per unit. The single-line production capacity is approximately 180 units per year, with an average gross profit margin of approximately 40-50%. In Vivo Gene Delivery Instrument use specific electric fields or physical methods to introduce exogenous genes or other substances into living cells or tissues. They transiently increase the permeability of cell membranes, allowing DNA and other substances to enter cells, thereby achieving gene transfer and expression. They are widely used in cell engineering, gene therapy, and DNA vaccine research. 
Upstream raw materials primarily include precision mechanical parts (frames, syringe pumps), electronic components (high-voltage pulse generators, circuit boards, chips), specialty materials (medical-grade plastics, precious metal electrodes), and supporting biochemical reagents. Downstream applications directly serve cutting-edge biotechnology fields, focusing on cell engineering, gene therapy, gene editing, and DNA vaccines.

North American market for In Vivo Gene Delivery Instrument was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for In Vivo Gene Delivery Instrument was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for In Vivo Gene Delivery Instrument was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of In Vivo Gene Delivery Instrument include BTX, Gibco, Lonza, Bio-Rad, BEX, Ningbo Scientz Biotechnology, Shanghai Qiwen Biotechnology, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for In Vivo Gene Delivery Instrument, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of In Vivo Gene Delivery Instrument by region & country, by Type, and by Application.

The In Vivo Gene Delivery Instrument market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Gene Delivery Instrument.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of In Vivo Gene Delivery Instrument manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of In Vivo Gene Delivery Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of In Vivo Gene Delivery Instrument in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

In Vivo Gene Delivery Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-10-29

Pages: 105 Pages

Report ld: 5291076

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now